- Home
- GLUE vs RGC Comparison
GLUE vs RGC Comparison
Compare GLUE & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLUE
- RGC
- Stock Information
- Founded
- GLUE 2019
- RGC 2014
- Country
- GLUE United States
- RGC Hong Kong
- Employees
- GLUE N/A
- RGC N/A
- Industry
- GLUE Biotechnology: Pharmaceutical Preparations
- RGC Medicinal Chemicals and Botanical Products
- Sector
- GLUE Health Care
- RGC Health Care
- Exchange
- GLUE Nasdaq
- RGC Nasdaq
- Market Cap
- GLUE N/A
- RGC 377.5M
- IPO Year
- GLUE 2021
- RGC 2021
- Fundamental
- Price
- GLUE $4.14
- RGC $290.05
- Analyst Decision
- GLUE Buy
- RGC
- Analyst Count
- GLUE 3
- RGC 0
- Target Price
- GLUE $14.33
- RGC N/A
- AVG Volume (30 Days)
- GLUE 573.6K
- RGC 122.6K
- Earning Date
- GLUE 05-08-2025
- RGC 06-20-2025
- Dividend Yield
- GLUE N/A
- RGC N/A
- EPS Growth
- GLUE N/A
- RGC N/A
- EPS
- GLUE 0.08
- RGC N/A
- Revenue
- GLUE $159,487,000.00
- RGC N/A
- Revenue This Year
- GLUE N/A
- RGC N/A
- Revenue Next Year
- GLUE N/A
- RGC N/A
- P/E Ratio
- GLUE $54.46
- RGC N/A
- Revenue Growth
- GLUE 14889.38
- RGC N/A
- 52 Week Low
- GLUE $3.21
- RGC $3.03
- 52 Week High
- GLUE $12.40
- RGC $268.73
- Technical
- Relative Strength Index (RSI)
- GLUE 45.31
- RGC 90.37
- Support Level
- GLUE $3.76
- RGC $27.70
- Resistance Level
- GLUE $4.62
- RGC $268.73
- Average True Range (ATR)
- GLUE 0.35
- RGC 31.00
- MACD
- GLUE -0.03
- RGC 21.78
- Stochastic Oscillator
- GLUE 40.35
- RGC 92.36
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.